Abstract

Background: Assessing the clinical relevance of non-tuberculous mycobacteria (NTM) isolated from respiratory samples can be challenging. The epidemiology of NTM species and their pathogenicity vary geographically, which can be important to guide clinical decision making. Objectives: ­ We aimed to outline the epidemiology of respiratory NTM isolates in Belgium and to assess their clinical relevance since Belgian data are scarce. Methods: We performed a retrospective multicentre study of all patients identified from the laboratory database with ≥1 respiratory sample growing NTM from January 2010 through December 2017. We collected clinical, radiological and microbiological data by medical record review and assessed clinical significance according to ATS/IDSA criteria for NTM pulmonary disease (NTM-PD). Results: Of the 384 unique patients 60% were male, 56% had a smoking history and 61% had pre-existing lung disease. Mycobacterium avium complex (MAC), M. gordonae and M. xenopi were the most frequently isolated species: 53%, 15% and 8% respectively. 43% of patients met ATS/IDSA criteria of which 28% presented with fibrocavitary disease. NTM-PD was statistically correlated with weight loss (OR 3,59), fibrocavitary lesions (OR 4,45) and positive acid-fast staining (OR 9,28). The most pathogenic species were M. abscessus (11/12), M. malmoense (6/7) and M. intracellulare (41/64). Conclusion: In our study MAC was the most commonly isolated NTM species but M. abscessus was the most pathogenic. Clinicians should consider this local knowledge in treatment decision making. Prospective national data collection could further inform us on this topic.

Highlights

  • Non-tuberculous mycobacteria (NTM) are ubiquitous in the natural environment and household water systems [1, 2]

  • We aimed to outline the epidemiology of respiratory NTM isolates in our region, assess their clinical relevance according to the American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) criteria and explore the possibility of an association between clinical relevance and the radiological pattern on chest CT

  • We noted an increase in the number of respiratory NTM isolates from 51 in 2010 to 75 new isolations in 2017, whereas the number of new cases of NTM pulmonary disease (NTM-PD) remained approximately stable during our study period

Read more

Summary

Introduction

Non-tuberculous mycobacteria (NTM) are ubiquitous in the natural environment and household water systems [1, 2]. Over 180 different species have been identified, but only 32 have been reported causing human or animal disease [3]. Lung infections (NTM related pulmonary disease or NTMPD) account for 90% of NTM related disease. Patients with pre-existing lung disease like chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and non-CF bronchiectasis are predisposed [4,5,6,7,8]. To a lesser extent NTM can cause infections of skin, sinuses, lymph nodes, or even lead to disseminated disease in case of innate or acquired immunodeficiency [5, 9].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.